FDA Warning Aspen Pharmacare: Evaluating Compli...

By João L. Carapinha

March 20, 2025

The FDA warning Aspen Pharmacare issued to Aspen Pharmacare Holdings Limited on February 24, 2025, followed an inspection of their drug manufacturing facility, Aspen SA Sterile Operations (Pty) Ltd., located in Gqeberha, South Africa. The inspecti...
Pharmaceutical Innovation and Market Access: Insights from Fast Company’s 202...
Global Partnerships SCD in Africa
Molecular Insights into Angiogenesis in Colorectal Cancer
Enhancing Colorectal Cancer Screening Through Mail and Navigation Strategies
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
Deadline Boosts Colorectal Cancer Screening Uptake in TEMPO Trial
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Maternal Child Health in South Africa
Tackling the Tuberculosis Burden in Children: A Global Perspective
Dialysis Technology Innovations: Revolutionizing Patient Care with Portable S...
Rising Chronic Kidney Disease Burden: A Global Health Challenge from 1990 to ...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare